Imprese · 05/08/20031 min di lettura
Guideline for the Clinical Evaluation of Analgesic Drugs; Withdrawal of Guidance
Traduzione automatica locale · Lingua originale della fonte
Riepilogo
The Food and Drug Administration (FDA) is announcing the withdrawal of a guidance entitled "Guideline for the Clinical Evaluation of Analgesic Drugs," which was issued on December 1, 1992. The guidance is outdated and no longer reflects FDA's current thinking on development of analgesic drugs. FDA is revising the guidance and will issue a draft for public comment in the future.